دورية أكاديمية

Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301

التفاصيل البيبلوغرافية
العنوان: Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301
المؤلفون: Reungwetwattana, Thanyanan, Cho, Byoung Chul, Lee, Ki Hyeong, Pang, Yong Kek, Fong, Chin Heng, Kang, Jin Hyoung, Lee, Yun-Gyoo, Lim, Chun Sen, Danchaivijitr, Pongwut, Lim, Yueh Ni, Lee, Youngjoo, How, Soon Hin, Geater, Sarayut, Lee, Sung Sook, Min, Young Joo, Kim, Joo-Hang, Lee, Jong-Seok, Lee, Gyeong-Won, Soo, Ross A., Lee, Sae Young, Choi, SeokYoung, Ahn, Myung-Ju
المصدر: In Journal of Thoracic Oncology October 2023 18(10):1351-1361
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2023.06.016